Program Information
Diastology and New Echo Technologies Summit provides a unique opportunity for participants to view key opinion leaders and review updates in heart valve disease, diastology, new and emerging echo technologies, and contrast echocardiography.
The Summit is divided into four parts.
Heart Valve Disease is a state-of-the-art mini-symposium on new advances in valvular heart disease including epidemiology, clinical diagnostic approaches to mitral tricuspid and aortic regurgitation and aortic stenosis, as well as new approaches to valve repair including robotics and percutaneous and transcatheter techniques.
Diastology summit presents new advances in diastolic heart failure including new guidelines, epidemiology, clinical diagnostic approaches, effects of therapy for diastolic heart failure, and clinical trial results.
New Echo Technologies summit will highlight new and emerging applications in real time 3-D and 4-D echo, live 3-D TEE, 2-D strain, stress echo, cardiac resynchronization interventional echo, and appropriateness criteria.
Contrast Echocardiography is a state-of-the-art minisymposium on the basic principles of contrast echo, rest and stress LVO and EBD, myocardial perfusion, and new research applications. There also will be discussions of safety issues and clinical trials on pulmonary pressures.
Intended Audience
This activity is designed for cardiologists, cardiac surgeons, anesthesiologists, sonographers, nurses, cardiology fellows, and other health care professionals interested in heart valve disease, diastology, new echocardiographic technologies, and contrast echocardiography.
Topics & Speakers
HEART VALVE DISEASE |
| Heart Valve Disease Summit Session 1: Mitral and Tricuspid Valve Disease |
- Keynote Address: State-of-the-Art of Imaging
in Valvular Heart Disease 2011: Guidelines,
Strengths, and Weaknesses
Linda D. Gillam, MD, FACC, FASE
- Epidemiology of Mitral Valve Regurgitation:
When Do We Intervene? Medicine or Surgery?
Brian P. Griffin, MD, FACC
- Quantification of Mitral Regurgitation:
From Basics to Advanced Measurements
Sherif F. Nagueh, MD, FACC, FASE
|
- Ischemic/Functional Mitral Regurgitation:
Mechanism, Treatment, and New Trials
Linda D. Gillam, MD, FACC, FASE
- Mitral Valve Surgery: Robotic Repair?
Edward Savage, MD
- Panel Discussion and Questions
|
| Heart Valve Disease Summit Session 2: Aortic Valve Disease and Percutaneous and Transcatheter Techniques |
- Columbia University Perspective
Linda D. Gillam, MD, FACC, FASE
- Cleveland Clinic Perspective
Brian P. Griffin, MD, FACC
|
- Surgeon’s Perspective
Edward Savage, MD
- Panel Discussion and Questions
|
| Workshop: Heart Valve Disease Cases |
- “Read-with-the-Experts” Session:
Mitral Regurgitation
Brian P. Griffin, MD, Coordinator
- “Read-with-the-Experts” Session:
Prosthetic Valve Dysfunction
Linda D. Gillam, MD, Prosthetic Valve Dysfunction
- “Read-with-the-Experts” Session: Mitral Stenosis
Juan Carlos Plana, MD
|
- “Read-with-the-Experts” Session:
Low Pressure Aortic Stenosis
Craig R. Asher, MD
- “Read-with-the-Experts” Session: Aortic Regurgitation
Annitta J. Morehead, RDCS
- “Read-with-the-Experts” Session:
Tricuspid Regurgitation
Allan L. Klein, MD
|
DIASTOLOGY
|
| Diastology Session 1: Epidemiology, Biology, Physiology, and Basic Doppler Assessment |
- Keynote Address: State-of-the-Art of Diastology
2011: Guidelines, Strengths and Weaknesses
Sherif F. Nagueh, MD, FACC, FASE
- Epidemiology: What Diseases?
How Do We Assess? Prognosis?
Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
|
- Biology, Physics, and Physiology of Diastolic Function:
The Basics
James D. Thomas, MD, FACC, FAHA, FESC, FASE
- Echo Doppler Assessment of Diastolic Function: Mitral
Inflow, Pulmonary Vein, Tissue Doppler Imaging, and
Color M-mode Doppler; Which One Do We Use
in Clinical Practice?
Sherif F. Nagueh, MD, FACC, FASE
|
| Diastology Session 2: Practical Techniques, Filling Pressures, and New Tools |
- Performing a Diastolic Exam: Elements Required
for Assessing the Left Ventricle
Annitta J. Morehead, BA, RDCS, CCRC, FASE
- Estimation of LV Filling Pressures Using Current
Diastology Tools: Pearls and Pitfalls
Juan Carlos Plana, MD, FACC
|
- New Advances in the Assessment of Diastolic Function
Using Strain and 2-D Strain: Added Value?
Theodore P. Abraham, MD, MBBS, FACC, FASE
|
| Diastology Session 3: Diseases with Diastolic Dysfunction |
- Pericardial Diseases: Is It Constriction or Restriction? Role of Pericardial Enhancement
by MRI
Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
- HCM: From Genetics to Myectomy — What’s New?
Craig R. Asher, MD, FACC
|
- Diastolic Evaluation in Coronary Artery Disease and
Hypertension: Separating Fact from Fiction
Theodore P. Abraham, MD, MBBS, FACC, FASE
|
Diastology Session 4: Therapy of Diastolic Function and Clinical Applications |
- Therapy of Diastolic Dysfunction: What Have We
Learned from Clinical Trials?
W. H. Wilson Tang, MD, FACC, FAHA
|
- Implementing the New Diastology Guidelines:
How Do We Manage the Clinical Setting? Pitfalls?
Discrepant Data?
Sherif F. Nagueh, MD, FACC, FASE
- Panel Discussion and Questions
|
| Workshop: Diastolic Function Exam Cases |
- “Read-with-the-Experts” Session:
Hypertrophic Cardiomyopathy
Craig R. Asher, MD, Coordinator
- “Read-with-the-Experts” Session: Noncompaction
Jacobo Kirsch, MD
- “Read-with-the-Experts” Session:
Hypertrophic Cardiomyopathy
Craig R. Asher, MD, Coordinator
- “Read-with-the-Experts” Session: Hypertension
Linda D. Gillam, MD
|
- “Read-with-the-Experts” Session:
Constrictive Pericarditis
Juan Carlos Plana, MD
- “Read-with-the-Experts” Session: Aortic Stenosis
Brian P. Griffin, MD
- “Read-with-the-Experts” Session:
Restrictive Cardiomyopathy
James D. Thomas, MD
|
| Implications of Hand Held Ultrasound Systems |
- Welcome and Introduction
Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
- Hand Held Ultrasound Systems – Chicago Perspective
Roberto M. Lang, MD, FACC, FASE
|
- Hand Held Ultrasound Systems — Oregon Perspective
Kevin S. Wei, MD, FACC
- Role of Hand Held Ultrasound Systems in
Screening Athletes
Craig R. Asher, MD, FACC
- Panel Discussion and Questions
|
NEW ECHOCARDIOGRAPHY TECHNOLOGIES
|
| New Echocardiography Technologies Session 1: 3-D Echo and Real-Time TEE |
- Assessment of LV Function with 3-D:
Strengths and Weaknesses
Roberto M. Lang, MD, FACC, FASE
- 3-D and 4-D Echo: Clinical Applications?
Work Flow Implications
James D. Thomas, MD, FACC, FAHA, FESC, FASE
|
- Real-Time Transesophageal 3D Echocardiography:
Incremental Value Over 2-D
Roberto M. Lang, MD, FACC, FASE
- Performing a 3-D Echo Examination: A Practical
Approach for Sonographers
Deborah A. Agler, RCT, RDCS, FASE
|
| New Echocardiography Technologies Session 2: 2-D Strain |
- 2-D Strain for Cardiac Function: Clinical Use?
Does It Have Prognostic Value?
Juan Carlos Plana, MD, FACC
- Tips and Techniques for Collecting Quality
Strain Data
Annitta J. Morehead, BA, RDCS, CCRC, FASE
|
- Role of Echo in Cardiac Resynchronization: What Is the
Current Indication? Future?
Theodore P. Abraham, MD, MBBS, FACC, FASE
- The Sonographer’s Role in CRT – Easy as One,
Two, Three
Deborah A. Agler, RCT, RDCS, FASE
|
New Echocardiography Technologies Session 3: Stress Echo, Atrial Fibrillation, Interventional Echo,
and Appropriateness Criteria |
- Stress Echocardiography: Should We Use Strain
Daily to Assess Wall Motion? Diastology Stress Test?
Theodore P. Abraham, MD, MBBS, FACC, FASE
- Role of Echo in Atrial Fibrillation: Does It Have a
Role in PV Ablation and LAA Closure?
Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
|
- Echo Guidance of Structural Heart Disease Interventions
Linda D. Gillam, MD, FACC, FASE
- Echocardiography: How Do We Use
Appropriateness Criteria?
Roberto M. Lang, MD, FACC, FASE
- Panel Discussion and Questions
|
Workshop: New Echo Technologies: 3-D, CRT and Strain, TEE and Stress Echo, Atrial Fibrillation
“Read-with-the-Experts” Session |
- Strain in Stress Echo
Juan Carlos Plana, MD, Coordinator,
- 3-D TEE
Linda D. Gillam, MD
- Strain
Sherif F. Nagueh, MD
- Atrial Fibrillation
Allan L. Klein, MD
|
- Percutaneous Valve Repair
Brian P. Griffin, MD
- CRT Responder and Nonresponder
Theodore P. Abraham, MD
- New Contrast Applications
Kevin S. Wei, MD
|
CONTRAST ECHOCARDIOGRAPHY
|
| Contrast Echocardiography Session 1: Contrast Basics, Physics, and Imaging Modalities |
- Keynote Address: State-of-the-Art of Contrast Echo
2011: Safety Issues, Strengths, and Weaknesses
Sharon L. Mulvagh, MD, FACC, FASE
- Contrast Physics 101: What Happens When You Combine Contrast Agents and Ultrasound?
Kevin S. Wei, MD, FACC
|
- Bring Value and Improvement to Your Echo Exam:
A Step-by-Step Guide to Collecting LVO Images
Annitta J. Morehead, BA, RDCS, CCRC, FASE
|
| Contrast Echocardiography Session 2: Left Ventricular Opacification and Perfusion |
- Clinical Decision Making Using Contrast Echo:
Rest and Stress Echo and ICU
Sharon L. Mulvagh, MD, FACC, FASE
- 3-D Contrast Echo: Can It Be Done?
What Does It Add?
Roberto M. Lang, MD, FACC, FASE
|
- How to Read Myocardial Perfusion:
How Do You Do
It?
Should We Be Doing This Routinely?
Kevin S. Wei, MD, FACC
|
| Workshop: “Read-with-the-Experts” |
- LVO and Stress Perfusion Cases
Kevin S. Wei, MD, Coordinator, Contrast Echo in ER
Allan L. Klein, MD, LAA Opacification
Sharon L. Mulvagh, MD, Perfusion Cases Rest and Stress
Sherif F. Nagueh, MD, Rest or Stress Echo LVO
Juan Carlos Plana, MD, Rest or Stress Echo LVO
James D. Thomas, MD, Rest or Stress Echo LVO
|
|
| Contrast Echocardiography Session 3: Clinical Trials and New Research Developments |
- Recent Clinical Trials on Contrast Echo:
Effects of Contrast on Pulmonary Hemodynamics
Sharon L. Mulvagh, MD, FACC, FASE
|
- New Research Developments in Contrast Echo:
Targeted Microbubbles, Vasovasorum Imaging
Kevin S. Wei, MD, FACC
- Panel Discussion and Questions
|
|
Learning Objectives
After viewing this activity, the participant will be able to do the following for each session:
| Heart Valve |
- Describe state-of-the-art imaging in valvular heart disease;
- Summarize the epidemiology, quantification, and
treatment strategies for both mitral and aortic regurgitation;
- Discuss surgical mitral valve repair including
robotic surgery;
|
- Describe controversies in the management of
aortic stenosis;
- Describe percutaneous and transcatheter approaches
to mitral and aortic diseases.
|
| Diastology |
- Describe the epidemiology, biology, and physiology
of diastolic function;
- Discuss the role of various echo Doppler approaches
to diastolic function assessment;
- Estimate left ventricular filling pressures using
current diastology tools;
- Describe practical techniques for performing a
diastolic examination and interpreting results;
|
- Diagnose diseases with impaired diastolic function
including pericardial diseases, cardiomyopathy, coronary
artery disease, hypertrophic obstructive cardiomyopathy,
hypertension, and pressure overload;
- Highlight clinical trials results and describe future trials;
- Discuss new ASE diastology guidelines.
|
| New Echocardiography Technologies |
- Discuss the clinical role of 3-D and 4-D echocardiography
in the assessment of cardiac function;
- Summarize advances in real-time TEE imaging;
- Discuss the role of strain in assessing cardiac function
and CRT;
- Describe the clinical practice role of stress
echocardiography in atrial fibrillation;
|
- Provide practical tips to acquire 3-D, strain, CRT images;
- Discuss echo guidance of structural heart interventions;
- Summarize the role of appropriateness criteria for echo.
|
| Contrast Echocardiography |
- Assess the safety, strengths, and weaknesses of current contrast echocardiography technologies;
- Explain the basics of contrast echocardiography,
including the contrast and ultrasound interaction;
- Describe the step-by-step approach to performing
left ventricular opacification;
- Summarize the role of contrast echo in clinical
decision making;
|
- Describe the role of contrast echo with stress echo
and 3-D echo;
- Interpret results from EBD, LVO, and
myocardial perfusion;
- Discuss new research developments and clinical trials
with contrast echocardiography.
|
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation
The Cleveland Clinic Foundation Center for
Continuing Education designates this enduring material for a
maximum of 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit
the credit hours to the American Osteopathic Association
Council on Continuing Medical Education for Category 2 credit.
Date of original release: May 1, 2011
Date of credit termination: August 31, 2013
CME credit is obtained upon successful completion of an activity
posttest and evaluation, as well as payment of a $30 processing fee.
|